A B S T R A C T
Background and Objectives
Hemoglobin Constant Spring or HbCS is a rare non-deletional α-thalassemia variant arising from a point mutation in the termination codon of the HbA2 gene (c.427T>C), resulting in the production of an elongated, unstable 173-amino-acid alpha-globin chain. This structural instability contributes to chronic hemolysis and ineffective erythropoiesis. Although most reported cases involve heterozygous carriers or compound heterozygotes, homozygous HbCS is exceptionally rare and has traditionally been associated with severe clinical manifestations including transfusion-dependent anemia, and complications presenting in infancy or early childhood. This study reports a familial case of homozygous HbCS in two generations of an Iranian family, characterized by late-onset presentation and a mild-to-moderate clinical phenotype.
Materials and Methods
We evaluated two related adult male patients, a 72-year-old father and his 47-year-old son, for longstanding fatigue and splenomegaly. We performed hematological assessments, hemoglobin electrophoresis, and molecular analyses, including gap-PCR for common α-thalassemia deletions and direct DNA sequencing (Sanger sequencing) of globin genes.
Results
Hematological evaluation revealed mild microcytic hypochromic anemia, with hemoglobin levels of 11.5 g/dL in the father and 11.2 g/dL in the son. Furthermore, MCV values were measured; 77.8 fL and 78.8 fL, in the father and the son, respectively. Hemoglobin electrophoresis demonstrated an HbCS fraction of 4.7% and 5.8% in the father and son, respectively. The father underwent a successful splenectomy for symptomatic splenomegaly. Molecular sequencing confirmed the homozygous c.427T>C (p.Ter143 Glnext∗31) mutation in the HbA2 gene in both patients, in the absence of concurrent β-globin gene mutations. In addition, both individuals carried heterozygous XmnI polymorphism.
Conclusions
This familial case demonstrates that homozygous HbCS does not necessarily associated with a severe, life-limiting pediatric disorder and may remain undiagnosed until late adulthood, with an indolent, mild clinical course. Given its potential to be misdiagnosed as iron deficiency anemia, due to electrophoretic co-migration, molecular testing of α-globin genes is essential in patients with unexplained microcytic anemia and splenomegaly, particularly in regions with high rates of consanguineous marriage. Accurate molecular diagnosis is pivotal for appropriate clinical management, cascade screening of at-risk relatives, and informed prenatal genetic counseling.